0
Adamas Pharmaceuticals Inc Banner Image

Adamas Pharmaceuticals Inc

  • Ticker ADMS
    Exchange NASDAQ More
  • Industry Drugs - Generic More
  • Sector Healthcare More
Adamas Pharmaceuticals Inc Logo Image
  • 51-200 Employees
  • Based in Emeryville, California
Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems in the United States. The company’s lead product candidate ADS-5102, which completed the Phase II/III clinical trial for the treatment of Parkinson's disease, known as levodopa induced dyskinesia.
Adamas Pharmaceuticals Inc

Most Recent Annual Report

Adamas Pharmaceuticals Inc
MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Adamas Pharmaceuticals Inc has reached its limit for free report views.

Adamas Pharmaceuticals Inc does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports